|
End-of-day quote
Korea S.E.
2026-10-19
|
5-day change | 1st Jan Change | ||
| 4,340.00 KRW | -7.76% |
|
-20.66% | -36.92% |
| Sep. 20 | Genome & Company(KOSDAQ:A314130) added to S&P Global BMI Index | CI |
| Aug. 14 | Genome & Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -7.76% | -20.66% | +27.84% | +19.72% | -36.92% | +64.08% | -31.55% | -75.99% | - | 185M | |
| +1.52% | -7.16% | -8.44% | +24.27% | +61.63% | +51.66% | +67.41% | +1.95% | - | 65B | |
| +1.52% | +7.17% | +12.39% | +8.00% | +14.02% | +10.77% | +77.89% | -15.30% | +232.72% | 51.2B | |
| +0.30% | +0.19% | -16.25% | -2.95% | +1.81% | +2.53% | +56.14% | +188.23% | +4,844.44% | 51.19B | |
| -0.38% | +1.40% | -1.48% | +30.40% | +17.95% | +25.39% | +42.37% | +6.77% | +253.52% | 43.93B | |
| +0.30% | +5.64% | +1.23% | +19.19% | +21.84% | +16.19% | +133.30% | -1.55% | +1,027.54% | 41.96B | |
| +2.35% | -6.08% | -5.50% | +0.98% | +128.69% | +237.25% | +528.10% | +562.85% | - | 38.14B | |
| +2.16% | +10.36% | +10.48% | +12.74% | +14.98% | +18.92% | +59.70% | +11.35% | +163.60% | 33.24B | |
| -0.90% | -10.49% | -4.27% | +30.34% | +53.31% | +37.09% | +1.80% | -58.05% | - | 25.2B | |
| +1.60% | +3.97% | +12.48% | +36.01% | +25.41% | +21.34% | +22.33% | -10.87% | +123.57% | 22.5B | |
| +1.71% | -6.92% | -8.97% | -3.20% | -6.29% | -17.36% | -4.32% | -66.06% | - | 22.03B | |
| -1.02% | -3.32% | -21.25% | -10.96% | -45.25% | -43.25% | +277.69% | +257.70% | +599.12% | 21.02B | |
| +0.19% | -0.06% | -0.73% | +17.38% | +10.33% | +13.82% | +169.93% | +233.74% | +1,913.19% | 17.26B | |
| -5.62% | -1.67% | -0.42% | -1.67% | +177.32% | +152.60% | +374.24% | +1,427.38% | +748.34% | 15.9B | |
| +0.72% | +4.78% | +9.54% | +12.88% | +43.01% | +81.47% | +200.91% | +191.53% | +444.10% | 15.42B | |
| +0.87% | +2.36% | +3.27% | +12.32% | +26.51% | +26.26% | +61.46% | -28.05% | +88.24% | 15.28B | |
| +2.09% | +1.30% | -3.22% | -8.66% | - | - | - | - | - | 14.79B | |
| -0.04% | -0.61% | +7.53% | +36.56% | +50.40% | +62.93% | +60.10% | -27.27% | +272.33% | 14.33B | |
| +3.10% | +1.66% | -2.08% | -7.07% | +15.25% | -1.40% | +496.31% | - | - | 13.77B | |
| -1.20% | +2.27% | -0.83% | +1.18% | -7.73% | -10.78% | -25.45% | -39.43% | +114.33% | 13.13B | |
| Average | +0.04% | -0.66% | +0.57% | +11.37% | +29.80% | +39.45% | +135.18% | +142.16% | +832.69% | 26.77B | |
| Weighted average by Cap. | +0.65% | -0.25% | -1.66% | +12.49% | +33.88% | +39.77% | +129.43% | +121.61% | +1,104.17% |
- Stock Market
- Stocks
- A314130 Stock
- Sector Genome & Company
Select your edition
All financial news and data tailored to specific country editions
